Zhejiang Xinkanghe Biomedical Technology Co., Ltd.

Innovative antibody research and development core technology platform

MORE +

Address the rapidly growing, unmet medical needs in the field of immunology

MORE +

Engage in advanced research in immunology, focus on global new antibody drug development

MORE +

scroll down

About Us

Kanova Biopharma was founded by a world-renowned immunologist in Nov. 2015. Based on its cutting-edge research in immunology,

Kanova focuses on developing first-in-class therapeutic antibodies or innovative combination therapies to treat cancer and autoimmune diseases.

2015

Company establishment

Office Location

47.5%

Personnel structure

Enterprise Introduction

Learn more

Core Team

Learn more

Honor

Learn more

Company History

2024

First phase Ⅲ clinical trial Meet Primary Endpoint

2023

B+ round of financing

2022

Clinical milestone

2021

B round of financing

2020

Core team

2019

First IND

2018

A round of financing

2017

XKH004 license-out

2016

Pre-A round of financing

2015

Kanova Biopharma was founded

Center of R&D

Continuous innovation lays the foundation for the company's product upgrading and technological innovation.

Source water valveProduct recommend

rotatex

rotatey

rotatez

R & D Team

Technology Platform

Patent Display

Information Center

2024-12-11

The phase III clinical trial of Xinkanghe IL-17A/F antibody drug for the treatment of ankylosing spondylitis has reached its research endpoint.

2021-07-31

First in class, Xinkanghe antibody drug XKH001 has been approved by the US FDA to enter clinical trials.

2020-12-22

The IND application for XinKanghe IL-17-A/F monoclonal antibody treatment for ankylosing spondylitis has been accepted by the CDE.

Learn More

Looking for more service content

Welcome domestic and foreign counterparts cooperation, joint research and development, mutual benefit, to achieve a win-win situation

immediate consultation

Home About Center of R&D Pipeline Cooperation Agency Information Center Join Contact

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Beijing Address: A203, Zhongguancun Biomedical Park, No.5, Development Road, Haidian District, Beijing
Zhejiang Address: Floor 8, Building 7, Dongsheng Huigu, 1299 Kehai Avenue, Keqiao District, Shaoxing City, Zhejiang Province
Contact Phone:010-82176552
E-mail:hr@kanovabiopharma.com

Power by：300.cn Beijing

SEO Tags

Business License